David Freyer, DO, MS
Professor of Clinical Pediatrics
Biography
Dr. David Freyer joined Children's Hospital Los Angeles in January 2008. As Director of the LIFE Program, he oversees all aspects of its services, which include clinical assessments of more than 350 patients annually, research regarding their long-term outcomes, and training of fellows, residents, and other health care professionals in the care of childhood cancer survivors. His clinical and research activities have focused principally on cancer survivorship and cancer control, including the recognition, management and prevention of short-and long-term morbidity of treatment, as well as health care transition for young adult survivors of childhood cancer, adolescent and young adult (AYA) oncology, palliative care, and decision-making at the end of life. Dr. Freyer is a member of the Children's Oncology Group where he serves as chair of the AYA Committee, on the Steering Committees for the Survivorship & Outcomes and Cancer Control Committees, and on several protocol and administrative committees. Dr. Freyer graduated magna cum laude from DePauw University, obtained his medical degree from the Des Moines University College of Osteopathic Medicine and Surgery, and completed post-graduate medical training at Chicago College of Osteopathic Medicine and Hospitals, Rush University Medical Center and the University of Michigan Medical Center. In 2007, he obtained a MS degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health.
Publications
Survival of Adolescents and Young Adults with Prevalent Poor-Prognosis Metastatic Cancers: A Population-based Study of Contemporary Patterns and Their Implications.
Cancer Epidemiol Biomarkers Prev. 2022 Jan 27;. doi: 10.1158/1055-9965.EPI-21-0913. Epub 2022 Jan 27. PubMed PMID: 35086824;
Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates.
Oncologist. 2022 Jul 5;27(7):579-586. doi: 10.1093/oncolo/oyac052. PubMed PMID: 35427410; PubMed Central PMCID: PMC9255970.
Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.
J Clin Oncol. 2022 May 20;40(15):1623-1634. doi: 10.1200/JCO.21.02669. Epub 2022 Mar 16. PubMed PMID: 35294262; PubMed Central PMCID: PMC9113216.
Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.
Oncologist. 2022 May 6;27(5):363-370. doi: 10.1093/oncolo/oyac030. PubMed PMID: 35522559; PubMed Central PMCID: PMC9074986.
Southern California Pediatric and Adolescent Cancer Survivorship (SC-PACS): Establishing a Multi-Institutional Childhood, Adolescent, and Young Adult Cancer Survivorship Consortium in Southern California.
Cureus. 2022 Feb;14(2):e21981. doi: 10.7759/cureus.21981. Epub 2022 Feb 7. PubMed PMID: 35282564; PubMed Central PMCID: PMC8906349.